New Light on an Old Problem. Photodynamic Therapy for Atherosclerosis**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 52, Issue 12, 2008, Pages 1033-1034

  Muller, James E ^a  

^a INFRAREDX INC   (United States)

Author keywords

ablation of inflammation; photodynamic therapy; plaque stabilization; vulnerable plaque

Indexed keywords

AMINOLEVULINIC ACID; LUTETIUM TEXAPHYRIN; MV 0611; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; EDITORIAL; ERYTHEMA; HUMAN; MACROPHAGE; NONHUMAN; PARESTHESIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT; RASH;

ANIMALS; ATHEROSCLEROSIS; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 50949121492     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.06.022     Document Type: Editorial

References (11)

1. Waksman R., McEwan P.E., Moore T.I., et al. PhotoPoint photodynamic therapy promotes stabilization of atherosclerotic plaques and inhibits plaque progression. J Am Coll Cardiol 52 (2008) 1033-1034
2. Castano A.P., and Hamblin M.R. PDT for cardiovascular disease. In: Hamblin M.R., and Mroz P. (Eds). Advances in Photodynamic Therapy: Basic, Translational and Clinical (2008), Artech House, Inc, Norwood, MA 375-394
3. Katoh T., Asahara T., Naitoh Y., et al. In vivo intravascular laser photodynamic therapy in rabbit atherosclerotic lesions using a lateral direction fiber. Lasers Surg Med 20 (1997) 373-381
4. Hsiang Y.N., Todd M.E., and Bower R.D. Determining light dose for photodynamic therapy of atherosclerotic lesions in the Yucatan miniswine. J Endovasc Surg 2 (1995) 365-371
5. Tawakol A., Castano A.P., Gad F., et al. Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor. Photochem Photobio Sci 7 (2008) 33-39
6. Hayase M., Woodbum K.W., Perlroth J., et al. Photoangioplasty with local motexafin lutetium delivery reduces macrophages in a rabbit post-balloon injury model. Cardiovasc Res 49 (2001) 449-455
7. Jenkins M.P., Buonaccorsi G.A., Raphael M., et al. Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty. Br J Surg 86 (1999) 1258-1263
8. Kereiakes D.J., Szyniszewski A.M., Wahr D., et al. Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary intervention and stent deployment: procedural and long-term results. Circulation 108 (2003) 1310-1315
9. Gerrity R.G., Natarajan R., Nadler J.L., and Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 50 (2001) 1654-1665
10. Cutlip D.E., Chhabra A.G., Baim D.S., et al. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 110 (2004) 1226-1230
11. Cheruvu P.K., Finn A.V., Gardner C., et al. Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol 50 (2007) 940-949